Teradyne CEO Gregory Smith sells $1.35 million of stock under pre-set plan
The sale of 4,000 shares at $337.83 came months after Smith adopted a trading plan, and well before a sharp drop in the stock, which complicates any reading of it as a signal.

Gregory Stephen Smith, president and chief executive of Teradyne (NASDAQ:TER), sold 4,000 shares of the company's common stock on September 15, 2026, at $337.83 each, for a total of $1,351,320, according to a regulatory disclosure summarised by Investing.com. After the transaction he directly holds 108,495.4075 shares.
The sale represents roughly 3.5% of the shares Smith held directly before it. It was carried out under a Rule 10b5-1 plan he adopted on February 12, 2026, about seven months earlier. Such plans let insiders fix the terms of future trades in advance, which is intended to separate the decision to sell from any information they might later acquire.
That timing matters for interpretation. Since the sale, Teradyne shares have fallen to $249.55, a decline of about 26% from Smith's sale price, amid broader weakness in semiconductor test equipment stocks. A pre-scheduled sale ahead of a slide can look prescient, but a plan set in February offers little basis for inferring that the chief executive anticipated the drop.
At the lower price, Teradyne trades at a price-to-earnings ratio of 28.75 and has a market capitalisation of about $38.96 billion. Those figures describe a company still valued as a growth story, even after the pullback.
The operating backdrop is the main support for that valuation. Teradyne reported third-quarter non-GAAP earnings of $2.29 per share on revenue of $1.31 billion, ahead of analyst estimates of $2.08 and $1.26 billion. It was the third straight quarter in which revenue held at $1.3 billion, a level management has called a high-water mark. AI-related products accounted for more than 60% of sales, underscoring how far the company has moved toward data-center and compute demand. It also introduced new products aimed at next-generation AI devices.
Analysts are broadly constructive on the outlook. Jefferies initiated coverage with a buy rating and a $284 price target, above the current share price. The firm expects the automated test equipment market to grow from roughly $9 billion in 2025 to $25 billion by 2030, and it sees Teradyne's system-on-chip share rising as Nvidia and hyperscalers dual-source their testing. Management has pointed to continued growth in 2027, with contributions from compute, memory and robotics.
Taken together, the episode is less a verdict on the chief executive's conviction than a reminder of how volatile the AI hardware supply chain remains. Strong earnings and bullish sector forecasts have not insulated the shares from a sector-wide retreat. Source: Investing.com.